Endocyte, Inc.

 

 Download Profile

Website	http://www.endocyte.com
Park	Purdue Research Park of West Lafayette
Building	Purdue Technology Center
Contact Information	n/a
News Stories	Data on Endocyte's Vintafolide and Etarfolatide to be presented at the 3rd European Lung Cancer Conference Endocyte Added to NASDAQ Biotechnology Index(R) Endocyte Announces Presentations at AACR Annual Meeting 2012 Endocyte Announces Results of Supplemental Analyses of PRECEDENT Trial Endocyte Inc. to present at upcoming investment conferences Endocyte Receives USAN Approval for Nonproprietary Names of Novel Endocyte Drug Candidates Endocyte Reports Fourth Quarter and Year End 2011 Financial Results and Operations Update Purdue Research Park celebrates 50th year
Business Classification	Life Sciences
Business Service	High Tech

About Endocyte, Inc.

Endocyte is a publicly traded (NASDAQ: ECYT) biotechnology company developing targeted therapies for the treatment of cancer and other serious diseases.